Trial Information

Summary: A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients

Status: Completed

Protocol Number: ML17910

Sponsor: Roche Farma SA

Company Division: Pharmaceutical

Official Scientific Title: An open-label pilot study of Zenapax in combination with CellCept and sirolimus on the prevention of acute rejection in patients receiving a heart transplant at risk of impaired kidney function

Brief Summary: This study will evaluate the efficacy and safety of intravenous Zenapax in combination with oral CellCept and oral sirolimus in patients receiving a heart transplant, and at risk of impaired kidney function. The anticipated time on study treatment is 3-12 months, and the target sample size is <100 individuals. Target sample size is 44.

Study Phase: IV

Study Design / Study Details:

  • Purpose: Treatment
  • Allocation: Non-Randomized
  • Masking: Open Label
  • Control: Uncontrolled
  • Assignment: Single Group
  • Endpoints: Safety/Efficacy

Study Type:

Interventional

Condition: Heart Transplantation

Intervention Type: Drug

Intervention Name: mycophenolate mofetil[CellCept]

Primary Outcome: 1. Efficacy: Proportion of patients experiencing a biopsy-proven acute rejection episode at end of study

Key Secondary Outcomes: 1. Safety; Adverse events, laboratory abnormalities, opportunistic infections, patient and graft survival, malignancies

Inclusion Criteria:

  • adult patients >=18 years of age;
  • single organ (heart) transplant recipients;
  • at risk for post-transplant renal dysfunction.

Exclusion Criteria:

  • previous organ transplant;
  • previous treatment with CellCept, Zenapax or sirolimus;
  • positive for human immunodeficiency virus (HIV) infection;
  • history of malignancy within the last 5 years, except localized and treated skin cancer, treated and without evident relapse.

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Trial Registration Date: 10/27/2005

Date Last Updated: 08/18/2008

Link To Trial Results

Contact:

Research Site:
Located In:
Madrid, Spain, 28046
Telephone: 973-235-5000 or 800-526-6367

  

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 20, 2008 at 2:16:05 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA